Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radiotherapy for brain tumors.

M P Mehta1, W A Tomé, G H Olivera

  • 1Department of Human Oncology, University of Wisconsin, 600 Highland Avenue, Madison, WI 53792, USA. mehta@mail.humonc.wisc.edu

Current Oncology Reports
|December 21, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low Levels of Acute Toxicity Associated With Proton Therapy for Low-Grade Glioma: A Proton Collaborative Group Study.

International journal of radiation oncology, biology, physics·2016
Same author

Clinical Outcomes of Proton Radiotherapy for Uveal Melanoma.

Clinical oncology (Royal College of Radiologists (Great Britain))·2016
Same author

Semi-automatic cone beam CT segmentation of in vivo pre-clinical subcutaneous tumours provides an efficient non-invasive alternative for tumour volume measurements.

The British journal of radiology·2015
Same author

Time series prediction of lung cancer patients' breathing pattern based on nonlinear dynamics.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2015
Same author

Response to "comment on 'It is not appropriate to "deform" dose along with deformable image registration in adaptive radiotherapy'" [Med. Phys. 39, 6531-6533 (2012)].

Medical physics·2013
Same author

A dosimetric analysis of tomotherapy based intensity modulated radiation therapy with and without bone marrow sparing in gynecologic malignancies.

Technology in cancer research & treatment·2012

Recent radiotherapy advances for brain tumors include new technologies like radiosurgery and intensity-modulated radiotherapy. Understanding molecular responses and developing novel radiosensitizers are improving radiation therapy effectiveness.

Area of Science:

  • Radiation Oncology
  • Neuro-oncology
  • Molecular Biology

Background:

  • Significant technological and molecular advancements have occurred in brain tumor radiotherapy over the past two years.
  • A deeper comprehension of the interplay between cellular processes (angiogenesis, apoptosis, cell-cycle regulation, signal transduction) and ionizing radiation is crucial.

Purpose of the Study:

  • To review key technological innovations in brain tumor radiotherapy.
  • To discuss the role of molecular understanding in modulating radiation response.
  • To explore emerging radiosensitizers and gene-targeting strategies.

Main Methods:

  • Review of recent technological advances, including radiosurgery, fractionated stereotactic radiotherapy, and intensity-modulated radiotherapy.
  • Analysis of molecular mechanisms influencing radiation response.

Related Experiment Videos

  • Exploration of novel radiosensitizing agents and radiation-induced gene promoters.

    • Main Results:

    • Technological progress has enhanced precision in radiotherapy delivery.
    • Molecular insights reveal "new agents" as effective modulators of radiation response.
    • Radiation-induced promoters offer potential for targeted gene expression in future conformal radiotherapy.

    Conclusions:

    • Advances in radiotherapy technology and molecular biology are transforming brain tumor treatment.
    • Targeted gene expression using radiation-induced promoters represents a promising future direction.
    • Novel radiosensitizers are expanding therapeutic options for brain tumors.